- Consultant / Postdoc; MD, PhD
- +47 22 78 17 52
After graduation from Medical University Vienna, Austria, Dr. Bischof underwent residency training in Obstetrics and Gynecology in Vienna and Bergen. In 2014, she enrolled the postgraduate PhD program at the Centre for Cancer Biomarkers at University of Bergen.
Her research background covers translational research in ovarian and endometrial cancer as well as preclinical model development. In 2019, she joined the department of Gynecologic Oncology at the Norwegian Radium Hospital where she is working as a consultant under ESGO certified training.
Besides her clinical activity, she is engaged in clinical studies and committed to biomedical research. She is a member of ENYGO, ESGO, NSGO, Norwegian Medical Association and Oesterreichische Aerztekammer.
CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinoma
EBioMedicine, 56, 102782
Influence of p53 Isoform Expression on Survival in High-Grade Serous Ovarian Cancers
Sci Rep, 9 (1), 5244
Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus
Cancer Res., 79 (3), 467-481
High expression of the p53 isoform γ is associated with reduced progression-free survival in uterine serous carcinoma
BMC Cancer, 18 (1), 684
Assessing the genetic architecture of epithelial ovarian cancer histological subtypes
Hum Genet, 135 (7), 741-56
The HDACi Panobinostat Shows Growth Inhibition Both In Vitro and in a Bioluminescent Orthotopic Surgical Xenograft Model of Ovarian Cancer
PLoS One, 11 (6), e0158208
Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study
Int J Epidemiol, 45 (5), 1619-1630
Shared genetics underlying epidemiological association between endometriosis and ovarian cancer
Hum Mol Genet, 24 (20), 5955-64